Transcatheter aortic valve implantation has been shown to be an effective and reproducible therapy for severe aortic valve stenosis. Device performance and short-term outcomes of well- deployed prostheses have been extensively investigated and discussed; however, these endpoints have not yet been reported in cases charac- terized by suboptimal expansion. We describe a case of CoreValve self-expanding prosthesis underexpansion, reporting data on prosthe- sis performance and short-term clinical outcome.
Consequences of underexpansion of a percutaneous aortic valve bioprosthesis
USSIA G;
2010-01-01
Abstract
Transcatheter aortic valve implantation has been shown to be an effective and reproducible therapy for severe aortic valve stenosis. Device performance and short-term outcomes of well- deployed prostheses have been extensively investigated and discussed; however, these endpoints have not yet been reported in cases charac- terized by suboptimal expansion. We describe a case of CoreValve self-expanding prosthesis underexpansion, reporting data on prosthe- sis performance and short-term clinical outcome.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.